| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.4M | +9.4% | +21.3% |
| Cost of Revenue | $4.0M | +22.8% | -72.5% |
| R&D Expense | $2.8M | -3.0% | -39.7% |
| SG&A Expense | $9.1M | +8.6% | -4.2% |
| Operating Income | -$8.5M | -9.5% | +80.6% |
| Pre-tax Income | -$8.5M | -24.0% | +80.8% |
| Income Tax | $14K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.1M | -14.0% | -65.1% |
| Accounts Receivable | $4.5M | +29.6% | -14.9% |
| Inventory | $8.4M | -18.3% | -48.3% |
| Current Assets | $48.8M | +14.4% | +3.9% |
| Total Assets | $79.1M | +4.0% | -9.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.2M | — | — |
| Investing Cash Flow | -$16.8M | — | — |
| Financing Cash Flow | $22.4M | — | — |
| +40.0% |
| -41.7% |
| Net Income | -$8.5M | -24.0% | +80.8% |
| EPS (Basic) | -$1.59 | +20.1% | -205.8% |
| EPS (Diluted) | -$1.59 | +20.1% | -205.8% |
| $23.0M |
| -5.0% |
| -30.3% |
| Total Liabilities | $29.3M | -4.5% | -24.0% |
| Stockholders' Equity | $49.8M | +9.8% | +1.9% |